Scott J. Rodig

Brigham and Women's Hospital — United States

Medicine · Health Sciences

129h-index76.4kcitations1.5kworks1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(429), Lung Cancer Treatments and Mutations(361), Lymphoma Diagnosis and Treatment(228), Cancer Genomics and Diagnostics(202), Immunotherapy and Immune Responses(148)

Publications1.5k total

Supplementary Data files from Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression
2025Open Access
Supplementary Tables from Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression
2025Open Access
Supplementary Figure 21 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 22. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 3 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 26 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Table 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 12 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 27 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 8 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 20 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 11 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 4. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 13 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 1. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 7 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
Supplementary Figure 29 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025Open Access
page 1 of 75Next →

Frequent Co-authors

Margaret A. Shipp(12), Gordon J. Freeman(10), Bjoern Chapuy(10), Pasi A. Jänne(8), Philippe Armand(7), Donna Neuberg(7), Catherine J. Wu(7), F. Stephen Hodi(7), Margaretha G.M. Roemer(7), Azra H. Ligon(6), Sachet A. Shukla(6), Anita Giobbie‐Hurder(5), Gad Getz(5), Kwok‐Kin Wong(5), Stephen M. Ansell(4), John M. Timmerman(4), Patrick A. Ott(4), Evisa Gjini(4), Jon C. Aster(4), Stefano Monti(4)